DiaMedica Therapeutics Inc.
DMAC
$3.85
$0.205.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 27.66% | 2.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.27% | 22.32% | |||
| Operating Income | 3.27% | -22.32% | |||
| Income Before Tax | 2.41% | -25.91% | |||
| Income Tax Expenses | -33.33% | 28.57% | |||
| Earnings from Continuing Operations | 2.44% | -25.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.44% | -25.92% | |||
| EBIT | 3.27% | -22.32% | |||
| EBITDA | 3.27% | -22.33% | |||
| EPS Basic | 2.55% | -25.75% | |||
| Normalized Basic EPS | 2.52% | -25.76% | |||
| EPS Diluted | 2.55% | -25.75% | |||
| Normalized Diluted EPS | 2.52% | -25.76% | |||
| Average Basic Shares Outstanding | 0.09% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||